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As asserted by numerous authors, Fourier Transform (FT)-Raman and FT-Infrared spec-
troscopies constitute two useful tools for bio-medical diagnostics. We can distinguish two
different kinds of application, namely, tissue disorders analyzed using statistical methods,
and detection of ectopic calciﬁcations through precise analysis of the shape and the po-
sition of absorption bands. In this contribution, we present some new results regarding
these research themes, as well as recent experimental developments, such as the ability to
perform nanometer scale near-ﬁeld infrared microscopy, which have already led to major
scientiﬁc breakthroughs.
© 2016 Published by Elsevier Masson SAS on behalf of Académie des sciences. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Infrared (IR) spectroscopy is an advantageous, non-
destructive and label-free technique for chemical analysis
[1e3]. IR absorption spectroscopy directly probes vibra-
tional energy levels and phonons of materials, providing
chemical as well as structural information by comparison
with data bank reference spectra [4e9]. In regards to the
medical ﬁeld, IR microscopy, when combined with
morphological description, has already demonstrated that
it is possible to obtain signiﬁcant clinical information
regarding microcrystalline pathologies [10e16] through
the analysis of concretions [17e28] as well as of ectopic
calciﬁcations in different human tissues [29e38]. Different
scientiﬁc breakthroughs have been obtained in other
research ﬁelds in which IR is now routinely used at the, UPMC Universite
S on behalf of Académie de
).hospitals. Among these, we can cite the characterisation of
lipids in graft liver at the Paul-Brousse hospital [39e41], of
different biological tissues at the Reims hospital [42e48],
and of concretions and ectopic calciﬁcations in kidney bi-
opsies for 30 years at the Necker hospital and subsequently
at the Tenon hospital [9,12,16,21,24,29].
The introduction of Fourier Transform-IR (FT-IR) spec-
troscopy into the hospital environment is intimately
related to experimental practicalities. Initially, the experi-
mental procedure to collect IR spectra was quite laborious,
requiring several minutes to collect data with sufﬁcient
signal-to-noise to extract signiﬁcant clinical information.
Thanks to various developments in laboratory apparatus, it
is now possible to collect data rapidly (seconds to milli-
seconds) on subcellular sized crystals. Such low acquisition
times allow the medical community to analyse large
numbers of biological samples. For example, at the Necker
and Tenon hospitals, more than 75,000 kidney stones have
been characterized. Such opportunities also facilitates sciences. This is an open access article under the CC BY-NC-ND license
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other major public health problems such as type II diabetes.
Indeed, we have started an investigation on more than 200
patients after kidney transplantation in order to establish a
possible correlation between the presence of ectopic cal-
ciﬁcations and kidney function. The acquisition of a latest
generation IR spectrometer at the Tenon hospital has also
offered the opportunity to characterize ectopic calciﬁca-
tions in more than 800 biopsies of different organs (not
only kidney but also breast and thyroid) originating from
different hospitals in France, Belgium, Italy, Switzerland,
and Canada.
In this contribution, we wish to present information
that clinicians and more especially anatomopathologists
can obtain through the conventional experimental setups,
which already exist in some hospitals. Also, wewill present
some very recent developments in the area of near-ﬁeld
imaging, which have made it possible to collect IR spectra
and images at about 20 nm resolution.2. Some basic equations related to IR spectroscopy
We will not present here the theoretical formalism
underlying IR spectroscopy but only some basic relevant
equations [49,50]. In transmission, neglecting the reﬂection
losses, the transmitted light (T) is a function of the ab-
sorption coefﬁcient (aabs) and of the path length of light in
the sample:
T ¼ I=I0 ¼ eaabs$l;
where I0 and I are the light intensity of the incident and
transmitted beams, respectively and l is the sample thick-
ness. If the sample is homogeneous and weakly absorbing,
scattering is negligible, and the absorbance is deﬁned as:
A ¼ g $ c $ l ¼ log T;
where aabs ¼ g $ c, g is the molar absorptivity and c is the
molar concentration of the absorbing species. Another key
point regarding IR spectroscopy is related to lateral reso-
lution of IR microscopes, which is limited by light
diffraction. This limit can be estimated by the Rayleigh
criterion:
x ¼ 2 $ l=NA;
where x is the lateral resolution and NA is the numerical
aperture of the microscope objective (the more
commonly found equation with x ¼ 0.61l/NA does not
hold true for reﬂective objectives such as Cassegrain and
Schwartzschild due to the central obscuring of the pri-
mary mirror). For mid-IR spectroscopy, the values of l are
between 25 mm (400 cm1) and 2.5 mm (4000 cm1).
Due to signal-to-noise constraints, diffraction limited
resolution is not achieved with conventional instruments
and it is necessary to use synchrotron radiation as the
source of photons [51e56] to attain this limit. The most
recent instrumental developments try to go beyond this
limit by using other physical principles. We will see that
it is possible now to collect IR spectra at the nanometer
scale.3. The FTIR spectrum of a biological tissue
It is convenient to conceptualize an IR spectrum as two
regions: 4000e1000 cm1 known as the functional group
region, and <1000 cm1 known as the ﬁngerprint region,
even if for many chemists the dividing line is in fact
1450 cm1. The functional group region contains relatively
few peaks, which are typically associated with the
stretching vibrations of functional groups (Fig. 1), denoted
by the Greek symbol n. In the ﬁngerprint region, the spectra
usually consist of bending vibrations within the molecule,
denoted by the Greek letter b. This region is the key to the
data analysis because it is here that each distinct compound
produces its own unique pattern of peaks, effectively a
ﬁngerprint. In Fig. 1B, the different, well understood, ab-
sorption bands of the calcium phosphate apatite are
assigned [8,9,57,58]. The n1 and n3 PeO stretching vibration
modes occur at 960e962 cm1 and 1035e1045 cm1,
respectively.
From an experimental point of view, a FTIR spectrum
can be collected using awide range of sampling techniques.
Those which we use at the hospital are depicted in Fig. 2.
FTIR spectra are usually collected in the transmission mode
(Fig. 2a), in which case kidney stones are ground with an
agate mortar and pestle. Then almost 3 mg of the resultant
powder is pelleted with spectroscopy grade dry KBr
(~300 mg).
In the case of kidney biopsies, tissues were simply
deposited on low-e slides (a glass slide on, which a metal
layer has been deposited making them IR reﬂective). Such
metal coated slides allowed us to measure IR spectra of
biopsies deposited on the glass slide in the so-called trans-
reﬂexion (or transﬂexion) mode (Fig. 2b). The dimension of
the spot can be as low as 10 mm using a synchrotron source
and thus, several thousands of IR spectra can be collected
allowing high-resolution chemical mapping of the sample
to be performed. Note that such mapping can be performed
in transmission mode (and thus without such support).
Then, through the selection of a speciﬁc IR band (red arrow
on Fig. 2c), it is possible to determine the spatial distribu-
tion (Fig. 2d) of a single chemical phase (here whewellite)
and overlay it with an optical image (Fig 2e).
Attenuated Total Reﬂectance (ATR) is another geometry
developed independently in the 1960s by Harrick and
Fahrenfort [59,60] and used at the hospital. FTIR-ATR
spectroscopy historically has been used for samples
which are too thick for transmission measurements
(Fig. 2f,g). In this sampling technique, information is
derived from an evanescent wave that extends the surface
of an infrared transparent crystal and penetrates only a
short distance into the sample, i.e. around 1e3 mm
depending on wavelength and crystal refractive index. We
may distinguish two kinds of experimental setup, namely,
macro and micro FTIR-ATR. In macro-ATR spectroscopy, the
whole sample is measured at once at depths of 1e3 mm,
giving no spatial resolution but excellent spectral quality. In
the micro-ATR conﬁguration, the coupling of the IR mi-
croscope and the ATR probe allows spatial resolution as ﬁne
as 2e4 mm [61,62] to be achieved, thanks to the high
refractive index crystal, which reduces the lateral beam
spot size.
Fig. 1. (a) Vibrational modes (stretching and bending), (b) identiﬁcation of the absorption bands in the case of breast tissues (1) and (2) respectively asymmetric
and symmetric stretching vibrations of PO 34 groups; (3) and (4), respectively, deformation and stretching vibrations of carbonate groups. In addition, several
protein bands (nNH at 3300 cm1, amide I and amide II at 1650 and 1550 cm1) can be observed.
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Fig. 2. Schematic diagram showing the IR beam path (a) in the transmission mode for the characterization of concretion, (b) in the reﬂexion mode for the
characterization of biopsies, (c) IR spectrum (d) Spatial distribution of whewellite as given by the intensity of the IR band. (e) Optical image of the kidney biopsy.
(f) Macro-ATR and (g) the micro-ATR crystal. In the macro-ATR accessory, an aperture is inserted to allow the beam from the top half of the lens to pass through
(from Ref. [63]).
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several spectral artefacts caused by sample induced scat-
tering of IR radiations in the transmission and trans-
reﬂexion modes to be eliminated.
4. Advantages of IR spectroscopy over other
characterization techniques
In recent years, chemical characterization methods for
identifying ions in concretions were widely used in hos-
pitals throughout the world because they are cheap and
easy to perform. However, such chemical methods present
a number of major disadvantages: ﬁrst, because they
identify ions and not molecules, it is impossible to distin-
guish different crystalline phases of the same molecule,
such as in the case of whewellite (calcium oxalate mono-
hydrate, COM) and weddellite (calcium oxalate dihydrate,
COD), which have very different etiopathogenic signiﬁ-
cance. COM is related to hyperoxaluria while COD indicates
hypercalciuria [64]. In the case of calcium phosphates,
apatite and brushite are not clearly distinguished. Note that
even X-ray scattering, still commonly used in hospitals, also
has somemajor drawbacks. For example, in apatite, it is not
possible to assess the carbonate level, which may be a
ﬁngerprint of an infectious process [65,66].
Finally, it is worth emphasizing that chemical methods
fail to identify some speciﬁc metabolites such as dihy-
droxyadenine, or crystallized drugs, or other rare compo-
nents related to speciﬁc pathological conditions. For all
these reasons, chemical methods (even X-ray scattering)
could advantageously be replaced by FTIR measurements
for stone analysis [13,67e69].
5. Large diversity of samples of interest for medicine
FTIR microspectroscopy has proven an efﬁcient tool in
the investigation of many tissue types. Quite recently, tu-
mours of liver [70,71], lung [72,73], stomach [74,75], oral
cavity [76], breast [77,78] or prostate [79] have been
addressed. Thanks to characteristic IR absorption peaks,
investigations of bones and other pathologic tissues [80],
collagens [81], fatty acids, lipid hydroperoxides [82],
atherosclerotic plaques [83] or creatine [84], can also be
assessed by FTIR spectroscopy. Note that several exciting
results have been obtained on brain [85e90]. For example,
in Huntington's disease, as the inclusions enriched in both
b sheets and b sheets/unordered structures are a charac-
teristic of severely affected brain regions, W. Andre et al.
[86] conclude that this kind of amyloid inclusion is likely to
be particularly toxic to neurons, while other inclusion types
may present less severe toxicity. All these papers show that
FTIR spectroscopy can be of great diagnostic and prognostic
value.
Another set of applications of FTIR spectroscopy address
the interaction of drugs with the tissue. For example, J-C.
Tsai et al. [91] have performed a noninvasive character-
ization of regional variation in drug transport into human
Stratum corneum in vivo. Another example is the publica-
tion of Z.W. Ye et al. [92] investigating the interaction be-
tween the anticancer drug erlotinib and human serum
albumin. In a recent review, A. Mignolet et al. [93] indicatethat results accumulated so far suggest that infrared spec-
troscopy could be a very accurate descriptor of the mode of
action of anticancer drugs. Similar results have been ob-
tained by A. Derenne et al. [94]. Their data suggest that FTIR
spectroscopy could be used for the classiﬁcation of drug
action.
Notably, human ﬂuids can be also investigated by FTIR
spectroscopy. A.K. Rosenthal and N. Mandel [95] have used
this technique to identify crystals in synovial ﬂuids and
joint tissues. A. Travo et al. [96] report some differences in
the chemical composition of tears from patients with ker-
atoconus and those from patients with non-speciﬁc in-
ﬂammatory ocular diseases. Recently, C.M. Orphanou [97]
has shown that human blood, saliva, semen and vaginal
secretions could successfully be detected and differentiated
from one another by ATR FT-IR spectroscopy.
A large number of publications deal with cells [98e102].
V. Erukhimovitch et al. [98] have used FTIR microscopy to
detect cells infected with viruses. Also, C. Chonanant et al.
[99] present SR-FTIR microspectroscopy evidence that this
is a sensitive technique for monitoring the differentiation
state of stem cells under chondrogenic induction, particu-
larly at an early stage.
Human pathogens such as enterococci can be studied. C.
Kirschner et al. [103] have shown the potential usefulness
of vibrational spectroscopic techniques in differentiating
enterococci from various sources, including isolates from
food, patient material, and strain collections. Similar results
have been obtained by the same team on candida [104].
Recently, very interesting studies have been published
in which FTIR spectroscopy is combined with ﬂuorescence
and luminescence experiments [105e111].
Finally, biomaterials have also been addressed. In a
recent study, X. Qiao et al. [112] have characterized hy-
droxyapatite nanoﬁbers generated by mineralization of
CaAlB3O7 powders in K2HPO4 solutions.
6. FTIR spectroscopy versus RAMAN spectroscopy
A large number of investigations are based on another
vibrational spectroscopy, namely Raman [113e116]. As
emphasized by K.C. Khulbe and T. Matsuura [117], infrared
and Raman spectra of a given molecule complement each
other. The symmetrical stretching, n1 (normal vibration) of
CO2 is infrared inactive, but active in Raman. On the con-
trary, the bending, n2, and asymmetric stretching, n3, vi-
brations are Raman inactive and infrared active.
These differences arise from the fact that infrared
spectroscopy exploits an absorption process dependent on
the permanent dipolar moment of a molecular bond, while
Raman spectroscopy is a scattering process related to a
modiﬁcation of the polarizability (induced change of the
dipolar moment) of the molecule.
Recently, C. Krafft et al. [118] have compared these two
spectroscopies in colon tissue applications. These authors
note that the advantages of FTIR imaging are related to
shorter acquisition times and higher spectral quality, while
Raman imaging displays better spatial and spectral reso-
lution. Signiﬁcant differences also exist with respect to the
preparation of biological tissue samples. Special attention
has to be paid to the support. The metal coated glass slides
M. Daudon, D. Bazin / C. R. Chimie 19 (2016) 1416e1423 1421used as alternatives to the more expensive CaF2 slides have
to be approached with caution because of dispersion arti-
facts in IR spectroscopy in reﬂection absorption mode [119]
and local surface-enhancement effects in Raman spec-
troscopy. This difﬁculty has been stressed by several au-
thors. For example, it has become apparent how the tissue
handled prior to FTIRmicro-spectroscopic imaging requires
special attention, particularly with regards to preservation
methods [120,121]. More precisely, infrared spectra of cells
and tissue samples are prone to baseline distortions from
Mie scattering as a result of samplemorphology [122]. Also,
other authors show that special attention has to be paid to
the ﬁxation protocol [123]. For all these reasons, M.J. Baker
et al. [124] describe a protocol for collecting IR spectra and
images from biological samples (e.g., ﬁxed cytology and
tissue sections, live cells or bioﬂuids) that assesses the
instrumental options available, appropriate sample prepa-
ration, different sampling modes as well as important ad-
vances in spectral data acquisition.
In the case of microcalciﬁcations, special attention has
also to be paid to the sample preparation procedure,
especially to the pH of the ﬁxation solution. This is due to
the fact that some chemical phases are very sensitive to the
pH and may be transformed or dissolved during the
process.
In Raman spectroscopy, the presence of intrinsic auto-
ﬂuorescence background signals, which are usually a few
orders of magnitude stronger than those arising from
Raman scattering, can be a strong limitation [125] andmust
be taken into account. Also, becausewe investigate samples
from patients, which are very fragile (organic material),
mFTIR, now implemented in the hospital, is preferable to
Raman spectroscopy.
7. New opportunities for FTIR beyond the diffraction
limit
One major drawback of FTIR microspectroscopy is
related to the wavelength of infrared light for which the
diffraction-limited spatial resolution is theoretically pre-
dicted to be around 5e20 mm in the mid-infrared region
(4000e400 cm1) [126]. To perform FTIR experiments
beyond this diffraction limit, it is necessary to collect the
signal in the near-ﬁeld, i.e. at a distance smaller than the
wavelength of the probing radiation (2.5e25 mm in the
mid-IR). To do so, we use a combination of IR spectroscopy
and atomic force microscopy (AFM), a technique which is
able to collect nanoscale-resolution images of the sample
topography by scanning a sharp tip over the sample.
As discussed previously by G. Ramer et al. [127], two
well-established techniques allowing such high-resolution
measurements exist. In the case of scattering Scanning
Near-ﬁeld Optical Microscopy or s-SNOM [128,129], the
AFM tip is illuminated by a focussed light beam, which
produces a strongly enhanced electromagnetic ﬁeld at the
tip apex due to the “lightning rod” effect. More precisely,
and as deﬁned by A. Centrone [50], the tip-mediated light-
sample interactionmodiﬁes the amplitude and phase of the
scattered light as a function of the local complex index of
refraction. Note that even if the resulting s-SNOM spectral
line shapes may not correlate with far-ﬁeld IR spectra, asimple model where the tip is approximate to a sphere of
radius (r) comparable to the tip apex allows interpretation
of a large fraction of s-SNOM data. The second technique
established by A. Dazzi at Paris-Orsay University is called
AFMIR [110,130,131]. It uses the microscale deformation of
the sample as it absorbs IR radiation at speciﬁcwavelengths
to record IR spectra at the nanometer scale. The AFM tip is
used to probe the local deformation and allows a topolog-
ical map of the sample to be recorded at the same time as
the chemical image at a single wavenumber. Tunable lasers
(OPO, QCL) are used to scan across frequencies and record
spectra over large spectral domains. One advantage of the
AFMIR technique is that the sample deformation is directly
proportional to the absorption and thus that AFMIR spectra
are equivalent to conventional far-ﬁeld IR transmission
spectra without the need for further processing, which
makes interpretation of the result considerably easier.
Coupling of the near-ﬁeld spectroscopy techniques with
synchrotron sources allows broadband nano-IR microscopy
in the whole mid-IR spectral domain and extending to the
far-IR.
8. Conclusion
In recent years, considerable effort has been exerted to
improve the performance of IR spectroscopy. Now, exper-
imental setups able to collect thousands of IR spectra with
sufﬁcient signal-to-noise ratio at the micrometer scale in
less than one hour are available in hospitals. Several
excellent papers using this technology have already been
published [132e136]. On large scale instruments or on
some speciﬁc devices, it is also possible to collect data at
the nanometer scale. Thus, the advent of large datasets
leading to major scientiﬁc breakthroughs in the next few
years is crystal clear.Acknowledgements
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